Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "drug costs"
Home
SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs
SK Plasma announced on Sept. 1 that it has begun distributing Revolpag Tablets 75 mg in South Korea, expanding its lineup following the August...
09/08/2026, 05:22 ET
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct symptoms, many cases have...
09/04/2026, 05:35 ET
From Retinal Scans to Brain Imaging: South Korea Backs Six Medical AI Tools for Fast-Track Hospital Adoption
Medical AI tools designed to assess cardiovascular risk from retinal images and analyze brain scans for stroke severity...
08/09/2026, 10:45 ET
Samsung Medical Center Adopts Next-Generation Da Vinci 5 Robot to Advance Lung and Esophageal Cancer Surgery
Samsung Medical Center has introduced the latest robot-assisted surgery platform, the Da Vinci 5, for lung and...
08/08/2026, 04:40 ET
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
08/06/2026, 04:41 ET
AI Platform Replaces Animal Models to Accelerate Parkinson’s Cell Therapy
Researchers are launching an international joint study that leverages artificial intelligence to evaluate whether...
08/01/2026, 04:21 ET
South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway
"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are...
07/31/2026, 09:57 ET
South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy
South Korean financial authorities are overhauling disclosure regulations across the pharmaceutical and biotechnology...
07/31/2026, 09:56 ET
Ilyang Pharmaceutical Commits 17.6 Billion Won to China Comeback with Flagship Wonbi-D
Ilyang Pharmaceutical is mounting a fresh push into the Chinese market, reviving a business operation that had been...
07/28/2026, 10:20 ET
'2 Million Brain Cells Die Every Minute': Neurologists Call for National Strategy as South Korea Ages
"In a super-aged society, brain diseases represent a core healthcare challenge that the nation must tackle...
07/26/2026, 08:05 ET
Previous
1
2
3
4
Next